PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program

Stock Information for PreveCeutical Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PreveCeutical Medical Inc.

PreveCeutical Secures $300,000 Loan and Resignation of a Director
PreveCeutical Partnership Leads to Two New Patent Filings
PreveCeutical Files Application to Human Ethics Committee to Acquire Human Tissue for the Final Phase of the Sol-Gel Program
PreveCeutical Announces Further Results from its Preliminary Screening of Peptides Derived from Blue Scorpion Venom in a Cell-Based Brain Cancer Model
PreveCeutical Announces Default Judgment Against JCN Capital Corp.
Retraction to News Release dated April 4, 2019
Asterion Welcomes Australian Government Awarding of Major Project Status for its Toowoomba Medicinal Cannabis Project
PreveCeutical Announces Default Judgment Against Essos Corporate Services Inc. and Detona Capital Corp.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.